Environmental, inhaled and ingested causes of pulmonary fibrosis
- PMID: 17325977
- DOI: 10.1080/01926230601064787
Environmental, inhaled and ingested causes of pulmonary fibrosis
Abstract
Pulmonary fibrosis is a general term that refers to a collection of connective tissue around alveolar structures. There are over 200 disorders where the lungs may be involved in a fibrotic response. To determine the cause of pulmonary fibrosis requires an in depth understanding of the pathogenesis of pulmonary fibrosis and breadth of knowledge of the causative agents and associated disorders that may lead to pulmonary fibrosis. A comprehensive evaluation of the patient is absolutely essential, starting with detailed history that includes an occupational and environmental history because fibrogenic exposures can occur in many settings. Equally important is a history of ingestion of pharmaceutical or nonpharmaceutical substances. A physical examination and judicious investigations are always a part of any comprehensive clinical assessment but they are not commonly helpful in elucidating the cause of most pulmonary fibrotic disorders. Although, a chest film is invariably done, a logical and strongly recommended next step is a high-resolution computed tomography (HRCT). HRCT provides a better assessment of the radiological pattern, may suggest a diagnosis as well as direct the site, and type of lung biopsy. If the history and investigations do not lead to a diagnosis then a lung biopsy is required. Prevention or removal of the inciting agent is critical to the treatment of these disorders and in some instances corticosteroids may be of help.
Similar articles
-
Lung fibrotic responses to particle exposure.Toxicol Pathol. 2007 Jan;35(1):148-53. doi: 10.1080/01926230601060009. Toxicol Pathol. 2007. PMID: 17325983
-
[Pulmonary biopsy in interstitial pneumopathies].Schweiz Med Wochenschr. 1981 Dec 5;111(49):1908-11. Schweiz Med Wochenschr. 1981. PMID: 6977183 French.
-
Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias.Am J Surg Pathol. 2007 Feb;31(2):277-84. doi: 10.1097/01.pas.0000213341.70852.9d. Am J Surg Pathol. 2007. PMID: 17255773
-
Challenges in pulmonary fibrosis: 6--Problematic granulomatous lung disease.Thorax. 2008 Jan;63(1):78-84. doi: 10.1136/thx.2004.031047. Thorax. 2008. PMID: 18156572 Review.
-
Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.Inhal Toxicol. 1996;8 Suppl:73-89. Inhal Toxicol. 1996. PMID: 11542496 Review.
Cited by
-
The natural history of progressive fibrosing interstitial lung diseases.Eur Respir J. 2020 Jun 25;55(6):2000085. doi: 10.1183/13993003.00085-2020. Print 2020 Jun. Eur Respir J. 2020. PMID: 32217654 Free PMC article.
-
Pulmonary inflammation triggered by ricin toxin requires macrophages and IL-1 signaling.J Immunol. 2009 Jul 15;183(2):1419-26. doi: 10.4049/jimmunol.0901119. Epub 2009 Jun 26. J Immunol. 2009. PMID: 19561099 Free PMC article.
-
Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.Stem Cell Rev Rep. 2015 Aug;11(4):598-620. doi: 10.1007/s12015-015-9587-7. Stem Cell Rev Rep. 2015. PMID: 25896401 Review.
-
Hypersensitivity Pneumonitis: An Interesting Case of Acute Shortness of Breath in a Young Patient.Cureus. 2024 Sep 5;16(9):e68683. doi: 10.7759/cureus.68683. eCollection 2024 Sep. Cureus. 2024. PMID: 39238923 Free PMC article.
-
Progressive plasterer's pneumoconiosis complicated by fibrotic interstitial pneumonia: a case report.BMC Pulm Med. 2019 Jan 7;19(1):6. doi: 10.1186/s12890-018-0776-4. BMC Pulm Med. 2019. PMID: 30616611 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical